文献速递重症综合管理与镇静镇痛

家庭ICU谵妄检测工具的开发与验证

Development and Validation of the Family ICU Delirium Detection Instrument.
PubMed 文献 · Crit Care Explor · 2026-01-02
一句话结论FIDDI由Sour Seven改编而成,在ICU患者中显示良好内部一致性(Cronbach's α=0.858)和可接受的结构效度,但是否优于现有谵妄检测策略尚需进一步研究。

本研究为横断面研究,在加拿大一家34张床的闭式综合成人ICU中,将Sour Seven改编为家庭ICU谵妄检测工具(FIDDI),并评估其可用性、信度和结构效度。共纳入51对患者-家庭成员配对,FIDDI的Cronbach's α=0.858,验证性因子分析显示模型拟合指标可接受(TLI=1.015,CFI=1.000,RMSEA=0.000,SRMR=0.044)。家庭成员认为工具易于使用且有助于理解谵妄,但部分成员将行为变化归因于医疗治疗或临床状况,提示需要进一步教育。结论认为FIDDI在ICU环境中显示出信度和结构效度,支持其作为家庭参与评估工具的潜力,但需进一步研究比较其与现有谵妄检测策略的价值。

要点

  • 在34张床的加拿大成人ICU中纳入51对患者-家庭成员配对,FIDDI内部一致性Cronbach's α=0.858。
  • 验证性因子分析显示可接受结构效度:TLI=1.015,CFI=1.000,RMSEA=0.000,SRMR=0.044。
  • 家庭成员报告FIDDI易于使用且有助于理解谵妄,但部分将行为变化归因于医疗治疗或临床状况。
  • 作者认为FIDDI有潜力作为家庭参与评估工具,但需进一步研究比较其与现有谵妄检测策略的价值。
  • 适用患者需无原发脑损伤、Richmond躁动-镇静评分≥-3且预计ICU停留至少24小时。

适用人群与场景

  • 纳入患者-家庭成员配对(dyads);患者需无原发脑损伤、Richmond躁动-镇静评分(RASS)≥-3、预计在ICU停留至少24小时以完成所有研究评估。
  • 研究在加拿大一家闭式34张床的成人综合ICU进行,提供三级医疗。

研究设计与关键结果

  • 研究类型为横断面研究,在加拿大一家34张床的闭式成人综合ICU进行,纳入51对患者-家庭成员配对。
  • 家庭成员中女性38人(75%),包括配偶17人(33%)、成年子女16人(31%)、兄弟姐妹10人(20%)。
  • FIDDI内部一致性Cronbach's α=0.858;验证性因子分析模型拟合指标:TLI=1.015,CFI=1.000,RMSEA=0.000,SRMR=0.044。
  • 家庭成员通过调查反馈工具易于使用且有助于理解谵妄,但部分将行为变化归因于医疗治疗或临床状况,提示需要进一步谵妄教育。

证据类型、等级与局限

  • 证据类型:横断面研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为FIDDI有潜力作为家庭参与谵妄评估工具,但需进一步研究测试其相对于当前谵妄检测策略的价值。
  • 家庭成员使用FIDDI时可能将患者行为变化归因于医疗治疗或临床状况,需注意进一步谵妄教育。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES BACKGROUND: Families play an important role in the care of ICU patients, yet their potential to contribute to the detection of delirium-a common and harmful complication-is often underutilized. This study aimed to adapt the Sour Seven to create the Family ICU Delirium Detection Instrument (FIDDI) and to assess its usability, reliability, and construct validity for delirium detection in ICU patients.

DESIGN: Cross-sectional.

SETTING: Canadian closed 34-bed general systems adult ICU providing tertiary level care.

PARTICIPANTS: Patient-family pairs (dyads) were included. Eligible patients had no primary brain injury, a Richmond Agitation-Sedation Scale score of greater than or equal to -3 and were expected to remain in the ICU for at least 24 hours to complete all study assessments.

INTERVENTIONS: Not applicable.

MEASUREMENTS AND MAIN RESULTS: The Sour Seven underwent adaptation using data from the Family ICU Delirium Detection Study and input from a multidisciplinary working group. The FIDDI was then tested for internal consistency using Cronbach's alpha and construct validity through confirmatory factor analysis. Family members provided feedback through surveys on the tool's usability and their experience with delirium detection. We enrolled 51 patient and family member pairs. Most family members were women (n = 38, 75%), including spouses (n = 17, 33%), adult children (n = 16, 31%), or siblings (n = 10, 20%). The FIDDI showed strong internal consistency (Cronbach's alpha = 0.858). The model fit indices indicated acceptable structure validity (Tucker-Lewis index [TLI] = 1.015, comparative fit index = 1.000, root mean square error of approximation = 0.000, and standardized root mean residual = 0.044). Family members reported that the tool was easy to use and helpful for understanding delirium, although some attributed behavioral changes to medical treatments or clinical conditions, highlighting the need for further education on delirium.

CONCLUSIONS: The Sour Seven was successfully adapted for the ICU environment (FIDDI) and pre-tested, demonstrating reliability and construct validity for detecting delirium in the ICU. These findings support its potential as a family-engaged assessment tool. Further research is needed to test the value of the FIDDI relative to current delirium detection strategies.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Krewulak KD, Arakawa NC, Deemer K, et al. Development and Validation of the Family ICU Delirium Detection Instrument. Crit Care Explor. 2026. PMID: 41481007. doi:10.1097/CCE.0000000000001335

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。